Design and development of disposable orbital shake bioreactors for pilot- and production-scale operations (up to 1'000 L) in the context of therapeutic protein production

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

9154.1;4 PFLS-LS

Projekttitel

Design and development of disposable orbital shake bioreactors for pilot- and production-scale operations (up to 1'000 L) in the context of therapeutic protein production

Projekttitel Englisch

Design and development of disposable orbital shake bioreactors for pilot- and production-scale operations (up to 1'000 L) in the context of therapeutic protein production

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Design and development of disposable orbital shake bioreactors for pilot- and production-scale operations (up to 1'000 L) in the context of therapeutic protein production
Abstract (Englisch)	The project consists in developing orbital shake bioreactors using single-use cell culture bags for working volumes up to 1'000 L. Fluid dynamics, oxygen transfer and power input will be mainly investigated together with more practical engineering aspects for the design and construction of pilot- and production-scale prototypes. As a result, the technology is expected to be clearly more flexible and cost-effective than standard equipment used in industrial bioprocessing, which should create excellent market opportunities.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Design and development of disposable orbital shake bioreactors for pilot- and production-scale operations (up to 1'000 L) in the context of therapeutic protein production

Abstract
(Englisch)

The project consists in developing orbital shake bioreactors using single-use cell culture bags for working volumes up to 1'000 L. Fluid dynamics, oxygen transfer and power input will be mainly investigated together with more practical engineering aspects for the design and construction of pilot- and production-scale prototypes. As a result, the technology is expected to be clearly more flexible and cost-effective than standard equipment used in industrial bioprocessing, which should create excellent market opportunities.